Adicet Bio Inc Strategic Asset Allocation Index
Adicet Bio Inc strategic asset allocation index. Adicet Bio Inc (ACET) has a Strategic Asset Allocation Index of 23.9% as of September 2023. Strategic assets (PP&E of $46.46 Million plus long-term investments of $-) total $46.46 Million, measured against net assets of $194.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ACET net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Adicet Bio Inc (2020–2021)
Strategic asset allocation index of Adicet Bio Inc from 2020 to 2021. This chart shows how Adicet Bio Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of September 2023, the index stands at 23.9%, representing strategic assets of $46.46 Million against net assets of $194.68 Million USD. Check Adicet Bio Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Adicet Bio Inc Strategic Asset Allocation Index by Year (2020–2021)
Adicet Bio Inc strategic asset allocation index by year from 2020 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Adicet Bio Inc from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Adicet Bio Inc market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.0% | $0.00 | $- | $0.00 | $303.13 Million | ▲ +0.0 pp |
| 2020 | 0.0% | $0.00 | $- | $0.00 | $109.83 Million | — |